Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
White adipose tissue (WAT) is specialized in storing energy in the form of
triacylglycerols, providing fatty acids (FA) according to the energy demand
of the individual, being expanded in obesity. Obesity is associated with the onset
of metabolic syndrome, which in turn correlates with WAT dysfunction that
includes changes in mitochondrial, metabolic and adipogenic genes expression
in adipocytes. We recently demonstrated that palmitoleic acid (C16:1n7), a
monounsaturated FA, increases the metabolic and oxidative capacity of 3T3-L1
adipocytes, modifying some bioenergetic parameters related to mitochondrial and
metabolic functions. However, there are no data about its effects on the expression
of WAT obesogenic genes from animals submitted to obesity by a high fat diet
(HFD). Thus, in the present work, male C57BL/6 mice were submitted to the
control diet (CO) or HFD for eight weeks. From the 5th week, the animals received
C16:1n7 (300 mg/kg/day) or water for 30 days, by gavage. After euthanasia, the
inguinal WAT was removed for analysis of ATGL, HSL, Perilipin, LPL, FABP4,
Lipin, GLUT-4, Adiponectin, Leptin, CEBP-alpha and PPAR-gamma by real time
RT-PCR gene expression. The following genes showed increased expression in the
HFD group: ATGL, HSL, LPL, Lipin, GLUT-4, Leptin, PPAR-gamma and CEBPalpha,
all of which were partially or completely reversed by the C16:1n7 treatment.
FABP4 expression was positively modulated in both the HFD and HFD+C16:1n7
groups, as well as the adiponectin. Accordingly, we suggest that palmitoleic acid is
modulating and/or adapting the mice WAT helping them to deal with the energy
demand from HFD. Thus, the animals treated with palmitoleic acid respond
differently from the obese group, and therefore, the imposed condition of obesity
by HFD.
Biography
Maysa Mariana Cruz is pursuing her PhD from Federal University of São Paulo. She is a Pharmacist. She has completed her Master of Science and has published one paper as first author and seven papers as coauthor.